Get complete Patent Opposition Report for Gilead Sciences

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Gilead Sciences against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2399588Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral PolymeraseIONIS PHARMACEUTICALSJan 7, 2021
EP3284520Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory ActivitySHIONOGIFeb 4, 2020
EP2955190Chemical CompoundsNUCANADec 17, 2018
EP3045206Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory ActivitySHIONOGIDec 6, 2018

Explore Gilead Sciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3595667Dec 20, 2023Pharmaceutical Compositions Comprising A Jak Inhibitor3
EP2655623Aug 30, 2023Non-Coding Immunomodulatory Dna Construct1
EP4070788Mar 22, 2023Pharmaceutical Formulations1
EP4070787Mar 1, 2023Pharmaceutical Formulations1
EP2709613Aug 12, 2020Methods For Treating Hcv1
EP3150586Jan 8, 2020Modulators Of Pharmacokinetic Properties Of Therapeutics3
EP3346995Aug 28, 2019Therapeutic Compositions For Treatment Of Human Immunodeficiency Virus3
EP3157932Jan 10, 2018Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate1
EP2682397Apr 19, 2017Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same3
EP2637664Mar 29, 2017Compositions And Methods Of Treating Pulmonary Hypertension6